174 related articles for article (PubMed ID: 20596245)
1. Immunofluorescence-based assay to identify modulators of the number of plasma membrane KCa3.1 channels.
Balut CM; Gao Y; Luke C; Devor DC
Future Med Chem; 2010 May; 2(5):707-13. PubMed ID: 20596245
[TBL] [Abstract][Full Text] [Related]
2. Role of ubiquitylation and USP8-dependent deubiquitylation in the endocytosis and lysosomal targeting of plasma membrane KCa3.1.
Balut CM; Loch CM; Devor DC
FASEB J; 2011 Nov; 25(11):3938-48. PubMed ID: 21828287
[TBL] [Abstract][Full Text] [Related]
3. ESCRT-dependent targeting of plasma membrane localized KCa3.1 to the lysosomes.
Balut CM; Gao Y; Murray SA; Thibodeau PH; Devor DC
Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1015-27. PubMed ID: 20720181
[TBL] [Abstract][Full Text] [Related]
4. Orai/CRACM1 and KCa3.1 ion channels interact in the human lung mast cell plasma membrane.
Duffy SM; Ashmole I; Smallwood DT; Leyland ML; Bradding P
Cell Commun Signal; 2015 Jul; 13():32. PubMed ID: 26177720
[TBL] [Abstract][Full Text] [Related]
5. Anterograde trafficking of KCa3.1 in polarized epithelia is Rab1- and Rab8-dependent and recycling endosome-independent.
Bertuccio CA; Lee SL; Wu G; Butterworth MB; Hamilton KL; Devor DC
PLoS One; 2014; 9(3):e92013. PubMed ID: 24632741
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels.
Brown BM; Shim H; Christophersen P; Wulff H
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():219-240. PubMed ID: 31337271
[TBL] [Abstract][Full Text] [Related]
7. Investigating CFTR and KCa3.1 Protein/Protein Interactions.
Klein H; Abu-Arish A; Trinh NT; Luo Y; Wiseman PW; Hanrahan JW; Brochiero E; Sauvé R
PLoS One; 2016; 11(4):e0153665. PubMed ID: 27092946
[TBL] [Abstract][Full Text] [Related]
8. Role of S3 and S4 transmembrane domain charged amino acids in channel biogenesis and gating of KCa2.3 and KCa3.1.
Gao Y; Chotoo CK; Balut CM; Sun F; Bailey MA; Devor DC
J Biol Chem; 2008 Apr; 283(14):9049-59. PubMed ID: 18227067
[TBL] [Abstract][Full Text] [Related]
9. Functional KCa3.1 channels regulate steroid insensitivity in bronchial smooth muscle cells.
Chachi L; Shikotra A; Duffy SM; Tliba O; Brightling C; Bradding P; Amrani Y
J Immunol; 2013 Sep; 191(5):2624-2636. PubMed ID: 23904164
[TBL] [Abstract][Full Text] [Related]
10. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
[TBL] [Abstract][Full Text] [Related]
11. Calcium-gated K
Tarasov MV; Bystrova MF; Kotova PD; Rogachevskaja OA; Sysoeva VY; Kolesnikov SS
Pflugers Arch; 2017 Feb; 469(2):349-362. PubMed ID: 28028617
[TBL] [Abstract][Full Text] [Related]
12. Globotriaosylceramide induces lysosomal degradation of endothelial KCa3.1 in fabry disease.
Choi S; Kim JA; Na HY; Cho SE; Park S; Jung SC; Suh SH
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):81-9. PubMed ID: 24158513
[TBL] [Abstract][Full Text] [Related]
13. Co-staining of K
Brömmel K; Maskri S; Bulk E; Pethő Z; Rieke M; Budde T; Koch O; Schwab A; Wünsch B
ChemMedChem; 2020 Dec; 15(24):2462-2469. PubMed ID: 33043595
[TBL] [Abstract][Full Text] [Related]
14. The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes.
Nicolaou SA; Neumeier L; Peng Y; Devor DC; Conforti L
Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1431-9. PubMed ID: 17151145
[TBL] [Abstract][Full Text] [Related]
15. Ca
Orfali R; Albanyan N
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677942
[TBL] [Abstract][Full Text] [Related]
16. PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus.
Wong R; Schlichter LC
J Neurosci; 2014 Oct; 34(40):13371-83. PubMed ID: 25274816
[TBL] [Abstract][Full Text] [Related]
17. Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
Vigneault P; Naud P; Qi X; Xiao J; Villeneuve L; Davis DR; Nattel S
J Physiol; 2018 Jun; 596(12):2359-2379. PubMed ID: 29574723
[TBL] [Abstract][Full Text] [Related]
18. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H
Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817
[TBL] [Abstract][Full Text] [Related]
19. Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca(2+)-activated K(+) channels: a novel target for medicinal chemistry efforts?
Balut CM; Hamilton KL; Devor DC
ChemMedChem; 2012 Oct; 7(10):1741-55. PubMed ID: 22887933
[TBL] [Abstract][Full Text] [Related]
20. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
Zhang Y; Feng Y; Chen L; Zhu J
Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
